Jiyuan Medical is a medical conglomerate with operations in innovative therapeutics gene-therapy development, high-end hospital medical service, and stem cell research. The Company has a strong focus on personalized medicine and high-end specialty healthcare in key fields including diabetes, cardiovascular diseases, and oncology.

The Company’s flagship products and services include human GLP-1 and FGF21 two gene modified stem cells gene-therapy for diabetes, stem cell storage, autologous mesenchymal stem cell storage, human umbilical mesenchymal stem cells storage, and autologous immune cell storage for anti-ageing use, and new therapy development. Other premium health care services include thermal texture mapping for personalized early disease diagnosis.